Latest News

Keep up to date with the latest news from Bayer’s businesses in the UK. Please note that some headline links may take you to other Bayer websites outside the UK. Medical information, including licensed uses and availability, may be different outside the region.

If you are looking for older headlines please get in touch at ukmedia.enquiries@bayer.com

1 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 96
Wednesday - February 22, 2017

Another record year for Bayer – good progress with the acquisition of Monsanto
Group sales increase by 1.5 percent (Fx & portfolio adj. 3.5 percent) to EUR 46,769 million / Substantial sales and earnings increases at Pharmaceuticals / Consumer Health grows with competition / Crop Science successful in a difficult market environment / EBITDA before special items improves by 10.2 percent to EUR 11,302 million / Net income raised by 10.2 percent to EUR 4,531 million / Core earnings per share increase by 7.3 percent to EUR 7.32 / Operating cash flow climbs by 20.8 percent to EUR 8,259 million / Forecast for 2017: further growth in sales and earnings more

Monday - December 12, 2016

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
BlueRock Therapeutics is focused on breakthrough treatments based on latest stem cell technology in combination with superior cell differentiation protocols / BlueRock Therapeutics’ vision is to cure diseases with significant cell loss and diminished self-repair potential with an initial focus on cardiovascular, neurological and other conditions
 more

Wednesday - November 09, 2016
Honey the puppy star of social media, finally finds a home after a year fighting a potentially fatal disease

HONEY I’M HOME!
more

1 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 96